David Staskin
Urology · Brighton, MANPI 1629165717
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 45.8% of the total. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 511 payments — averaging $797.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$186K
- Urovant Sciences Inc$113K
- Astellas Pharma US Inc$62K
- Ferring Pharmaceuticals Inc.$19K
- Laborie Medical Technologies Corp.$10K
- E.r. Squibb & Sons, L.L.C.$8K
- plus $9K from 15 others
Across 131 payments — averaging $3362.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urovant Sciences Inc$213K
- Sumitomo Pharma America, Inc.$187K
- Astellas Pharma Global Development$41K
What the payments were for
- Consulting fees$97,47624%
- Speaking & faculty fees$227,68056%
- Travel & lodging$70,09117%
- Food & beverage$12,0533%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 202 | $186,396 |
| Urovant Sciences Inc | 151 | $113,335 |
| Astellas Pharma US Inc | 60 | $61,830 |
| Ferring Pharmaceuticals Inc. | 30 | $18,803 |
| Laborie Medical Technologies Corp. | 1 | $10,000 |
| E.r. Squibb & Sons, L.L.C. | 3 | $7,500 |
| Antares Pharma, Inc. | 1 | $3,000 |
| Medtronic(2 entities) | 20 | $2,402 |
| AbbVie(2 entities) | 9 | $2,310 |
| Axonics, Inc. | 17 | $1,174 |
| Convatec Inc. | 4 | $158 |
| AstraZeneca | 2 | $86 |
| Boston Scientific | 1 | $76 |
| Johnson & Johnson | 1 | $48 |
| Coloplast | 2 | $47 |
| Myriad Genetic Laboratories, Inc. | 2 | $32 |
| 180 Medical, Inc. | 1 | $30 |
| Metuchen Pharmaceuticals | 1 | $22 |
| Dentsply IH Inc. | 1 | $20 |
| Amgen | 1 | $18 |
| Caldera Medical, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$407,300 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.
Other urology in Brighton
- Jairam EswaraBrighton$64K
- Christopher CutieBoston$3.5M
- Brian EisnerBoston$424K
- Liam HurleyNorth Andover$319K
- Stephen DretlerBoston$298K
- Abraham MorgentalerChestnut Hill$290K
- Louis LiouCambridge$278K
- Tony LuongoBoston$265K
- Ricardo MunarrizBoston$118K
- Andrew KramerHyannis$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.